Woodline Partners LP - 31 Mar 2025 SCHEDULE 13G Report for Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share (ALGS)

Filing Manager: Woodline Partners LP
Reporting Manager: Woodline Partners LP
Security: Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol: ALGS
Shares outstanding: 6.07M shares
Disclosed Ownership: 315K shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Date filed: 15 May 2025, 09:33
Date of event: 31 Mar 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Woodline Partners LP	5.2%	315K	0	315K	/s/ Erin Mullen	Erin Mullen, General Counsel & Chief Compliance Officer